| UniProt ID | TNAP3_HUMAN | |
|---|---|---|
| UniProt AC | P21580 | |
| Protein Name | Tumor necrosis factor alpha-induced protein 3 | |
| Gene Name | TNFAIP3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 790 | |
| Subcellular Localization |
Cytoplasm. Nucleus. Lysosome. A20p50: Cytoplasm. |
|
| Protein Description | Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF-alpha and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS-induced production of proinflammatory cytokines and IFN beta in LPS-tolerized macrophages.. | |
| Protein Sequence | MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWGVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRREGHAQNPMEPSVPQLSLMDVKCETPNCPFFMSVNTQPLCHECSERRQKNQNKLPKLNSKPGPEGLPGMALGASRGEAYEPLAWNPEESTGGPHSAPPTAPSPFLFSETTAMKCRSPGCPFTLNVQHNGFCERCHNARQLHASHAPDHTRHLDPGKCQACLQDVTRTFNGICSTCFKRTTAEASSSLSTSLPPSCHQRSKSDPSRLVRSPSPHSCHRAGNDAPAGCLSQAARTPGDRTGTSKCRKAGCVYFGTPENKGFCTLCFIEYRENKHFAAASGKVSPTASRFQNTIPCLGRECGTLGSTMFEGYCQKCFIEAQNQRFHEAKRTEEQLRSSQRRDVPRTTQSTSRPKCARASCKNILACRSEELCMECQHPNQRMGPGAHRGEPAPEDPPKQRCRAPACDHFGNAKCNGYCNECFQFKQMYG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAEQVLPQA ------CHHCHHHHH | 18.87 | 22814378 | |
| 11 | Phosphorylation | QVLPQALYLSNMRKA CHHHHHHHHHHHHHH | 15.88 | 23401153 | |
| 42 | Phosphorylation | GIIHHFKTMHRYTLE CCHHHHHHHHHHHHH | 19.78 | 30576142 | |
| 53 | Phosphorylation | YTLEMFRTCQFCPQF HHHHHHHHCCCCHHH | 10.21 | 30576142 | |
| 66 | Ubiquitination | QFREIIHKALIDRNI HHHHHHHHHHHCCCH | 34.18 | - | |
| 76 | Phosphorylation | IDRNIQATLESQKKL HCCCHHHHHHHHHHH | 18.06 | 23403867 | |
| 79 | Phosphorylation | NIQATLESQKKLNWC CHHHHHHHHHHHHHH | 50.87 | 23403867 | |
| 81 | Ubiquitination | QATLESQKKLNWCRE HHHHHHHHHHHHHHH | 69.38 | 21906983 | |
| 81 | Acetylation | QATLESQKKLNWCRE HHHHHHHHHHHHHHH | 69.38 | 129897 | |
| 82 | Ubiquitination | ATLESQKKLNWCREV HHHHHHHHHHHHHHH | 39.14 | 22817900 | |
| 108 | Phosphorylation | GNCLMHATSQYMWGV CCCEEEECCCHHCCC | 11.15 | 22617229 | |
| 118 | Phosphorylation | YMWGVQDTDLVLRKA HHCCCCCHHHHHHHH | 17.72 | 22617229 | |
| 124 | Ubiquitination | DTDLVLRKALFSTLK CHHHHHHHHHHHHHH | 45.33 | 25015289 | |
| 128 | Phosphorylation | VLRKALFSTLKETDT HHHHHHHHHHHHCCC | 33.41 | 22617229 | |
| 129 | Phosphorylation | LRKALFSTLKETDTR HHHHHHHHHHHCCCC | 34.22 | 22617229 | |
| 131 | Ubiquitination | KALFSTLKETDTRNF HHHHHHHHHCCCCCE | 59.67 | 25015289 | |
| 139 | Ubiquitination | ETDTRNFKFRWQLES HCCCCCEEEEEEHHH | 37.25 | - | |
| 141 | Ubiquitination | DTRNFKFRWQLESLK CCCCEEEEEEHHHCC | 22.33 | 21963094 | |
| 142 | Ubiquitination | TRNFKFRWQLESLKS CCCEEEEEEHHHCCC | 15.39 | 22817900 | |
| 159 | Phosphorylation | FVETGLCYDTRNWND HHHCCCCCCCCCCCH | 25.95 | 27642862 | |
| 161 | Phosphorylation | ETGLCYDTRNWNDEW HCCCCCCCCCCCHHH | 10.22 | 30108239 | |
| 179 | Phosphorylation | IKMASTDTPMARSGL HHHHCCCCCCCCCCC | 18.30 | - | |
| 217 | Phosphorylation | ISDKMLRSLESGSNF ECHHHHHHCCCCCCC | 32.31 | 30001349 | |
| 220 | Phosphorylation | KMLRSLESGSNFAPL HHHHHCCCCCCCCCE | 53.46 | 23401153 | |
| 222 | Phosphorylation | LRSLESGSNFAPLKV HHHCCCCCCCCCEEE | 37.75 | 30108239 | |
| 287 | Ubiquitination | RGRFEDLKVHFLTDP CCCHHCCEEEECCCC | 46.08 | 29967540 | |
| 299 | Ubiquitination | TDPENEMKEKLLKEY CCCCHHHHHHHHHHH | 45.58 | 29967540 | |
| 301 | Ubiquitination | PENEMKEKLLKEYLM CCHHHHHHHHHHHCC | 54.31 | - | |
| 306 | Phosphorylation | KEKLLKEYLMVIEIP HHHHHHHHCCEEEEC | 9.86 | 19413330 | |
| 307 | Ubiquitination | EKLLKEYLMVIEIPV HHHHHHHCCEEEECC | 2.01 | 22817900 | |
| 321 | Phosphorylation | VQGWDHGTTHLINAA CCCCCCCHHHEEEHH | 13.97 | 19413330 | |
| 322 | Phosphorylation | QGWDHGTTHLINAAK CCCCCCHHHEEEHHH | 21.19 | 19413330 | |
| 328 | Ubiquitination | TTHLINAAKLDEANL HHHEEEHHHHCCCCC | 14.41 | 22817900 | |
| 337 | Ubiquitination | LDEANLPKEINLVDD HCCCCCCCCCCCCHH | 74.52 | 29967540 | |
| 354 | Ubiquitination | ELVQHEYKKWQENSE HHHHHHHHHHHHCCH | 44.55 | 21963094 | |
| 355 | Ubiquitination | LVQHEYKKWQENSEQ HHHHHHHHHHHCCHH | 53.89 | 22817900 | |
| 376 | Phosphorylation | AQNPMEPSVPQLSLM CCCCCCCCCCCEEEE | 32.87 | 30108239 | |
| 381 | Phosphorylation | EPSVPQLSLMDVKCE CCCCCCEEEEEEEEC | 19.19 | 21712546 | |
| 397 | Phosphorylation | PNCPFFMSVNTQPLC CCCCEEEEECCCCCC | 13.68 | 30108239 | |
| 400 | Phosphorylation | PFFMSVNTQPLCHEC CEEEEECCCCCCHHH | 29.43 | 30108239 | |
| 420 | Acetylation | KNQNKLPKLNSKPGP HHHCCCCCCCCCCCC | 71.40 | 25953088 | |
| 423 | Phosphorylation | NKLPKLNSKPGPEGL CCCCCCCCCCCCCCC | 51.14 | 30108239 | |
| 424 | Ubiquitination | KLPKLNSKPGPEGLP CCCCCCCCCCCCCCC | 53.58 | 29967540 | |
| 430 | Ubiquitination | SKPGPEGLPGMALGA CCCCCCCCCCCCCCC | 2.94 | 21963094 | |
| 438 | Phosphorylation | PGMALGASRGEAYEP CCCCCCCCCCCCCCC | 38.73 | 28102081 | |
| 443 | Phosphorylation | GASRGEAYEPLAWNP CCCCCCCCCCCCCCC | 17.49 | 22210691 | |
| 453 | Phosphorylation | LAWNPEESTGGPHSA CCCCCCCCCCCCCCC | 30.59 | 26657352 | |
| 454 | Phosphorylation | AWNPEESTGGPHSAP CCCCCCCCCCCCCCC | 49.81 | 30108239 | |
| 459 | Phosphorylation | ESTGGPHSAPPTAPS CCCCCCCCCCCCCCC | 45.67 | 19276368 | |
| 463 | Phosphorylation | GPHSAPPTAPSPFLF CCCCCCCCCCCCCCC | 50.57 | 30108239 | |
| 466 | Phosphorylation | SAPPTAPSPFLFSET CCCCCCCCCCCCCCC | 26.31 | 30108239 | |
| 471 | Phosphorylation | APSPFLFSETTAMKC CCCCCCCCCCCEEEC | 35.86 | 28634298 | |
| 473 | Phosphorylation | SPFLFSETTAMKCRS CCCCCCCCCEEECCC | 20.75 | 28122231 | |
| 474 | Phosphorylation | PFLFSETTAMKCRSP CCCCCCCCEEECCCC | 22.24 | 28122231 | |
| 480 | Phosphorylation | TTAMKCRSPGCPFTL CCEEECCCCCCCCEE | 34.80 | 29214152 | |
| 502 | Ubiquitination | CERCHNARQLHASHA HHHCCCHHHHHHHCC | 44.93 | 22817900 | |
| 507 | Phosphorylation | NARQLHASHAPDHTR CHHHHHHHCCCCCCC | 14.94 | 28348404 | |
| 509 | Ubiquitination | RQLHASHAPDHTRHL HHHHHHCCCCCCCCC | 14.55 | 23000965 | |
| 520 | Ubiquitination | TRHLDPGKCQACLQD CCCCCCCCHHHHHHH | 28.67 | 21906983 | |
| 537 | Phosphorylation | RTFNGICSTCFKRTT HHHCCHHHHHHHHCC | 26.70 | 30108239 | |
| 538 | Phosphorylation | TFNGICSTCFKRTTA HHCCHHHHHHHHCCH | 19.97 | 30108239 | |
| 541 | Ubiquitination | GICSTCFKRTTAEAS CHHHHHHHHCCHHHH | 51.48 | 21906983 | |
| 548 | Phosphorylation | KRTTAEASSSLSTSL HHCCHHHHHHHCCCC | 16.38 | 30108239 | |
| 549 | Phosphorylation | RTTAEASSSLSTSLP HCCHHHHHHHCCCCC | 42.20 | 30108239 | |
| 550 | Phosphorylation | TTAEASSSLSTSLPP CCHHHHHHHCCCCCC | 24.68 | 30108239 | |
| 552 | Phosphorylation | AEASSSLSTSLPPSC HHHHHHHCCCCCCCH | 20.21 | 30108239 | |
| 553 | Phosphorylation | EASSSLSTSLPPSCH HHHHHHCCCCCCCHH | 39.31 | 30108239 | |
| 554 | Phosphorylation | ASSSLSTSLPPSCHQ HHHHHCCCCCCCHHC | 35.19 | 30108239 | |
| 563 | Phosphorylation | PPSCHQRSKSDPSRL CCCHHCCCCCCHHHH | 29.91 | 26699800 | |
| 565 | Phosphorylation | SCHQRSKSDPSRLVR CHHCCCCCCHHHHCC | 56.87 | 25056879 | |
| 568 | Phosphorylation | QRSKSDPSRLVRSPS CCCCCCHHHHCCCCC | 43.14 | 22817900 | |
| 573 | Phosphorylation | DPSRLVRSPSPHSCH CHHHHCCCCCHHCCC | 23.42 | 23401153 | |
| 575 | Phosphorylation | SRLVRSPSPHSCHRA HHHCCCCCHHCCCCC | 36.17 | 23401153 | |
| 578 | Phosphorylation | VRSPSPHSCHRAGND CCCCCHHCCCCCCCC | 18.27 | 30108239 | |
| 592 | Phosphorylation | DAPAGCLSQAARTPG CCCCCHHHHHHCCCC | 23.11 | 30108239 | |
| 597 | O-linked_Glycosylation | CLSQAARTPGDRTGT HHHHHHCCCCCCCCC | 27.22 | 29351928 | |
| 597 | Phosphorylation | CLSQAARTPGDRTGT HHHHHHCCCCCCCCC | 27.22 | 29214152 | |
| 609 | Ubiquitination | TGTSKCRKAGCVYFG CCCCCCCCCCEEEEC | 59.61 | 29967540 | |
| 614 | Phosphorylation | CRKAGCVYFGTPENK CCCCCEEEECCCCCC | 10.60 | 20090780 | |
| 617 | Phosphorylation | AGCVYFGTPENKGFC CCEEEECCCCCCCEE | 19.96 | 29396449 | |
| 621 | Ubiquitination | YFGTPENKGFCTLCF EECCCCCCCEEEEEE | 52.26 | - | |
| 625 | Phosphorylation | PENKGFCTLCFIEYR CCCCCEEEEEEEEEC | 25.05 | - | |
| 631 | Phosphorylation | CTLCFIEYRENKHFA EEEEEEEECCCCCEE | 20.57 | 20090780 | |
| 635 | Ubiquitination | FIEYRENKHFAAASG EEEECCCCCEEHHCC | 35.03 | - | |
| 641 | Phosphorylation | NKHFAAASGKVSPTA CCCEEHHCCCCCCCH | 34.13 | 23927012 | |
| 643 | Ubiquitination | HFAAASGKVSPTASR CEEHHCCCCCCCHHH | 36.72 | 21963094 | |
| 645 | Phosphorylation | AAASGKVSPTASRFQ EHHCCCCCCCHHHHH | 21.73 | 23927012 | |
| 647 | Phosphorylation | ASGKVSPTASRFQNT HCCCCCCCHHHHHCC | 29.74 | 23927012 | |
| 649 | Phosphorylation | GKVSPTASRFQNTIP CCCCCCHHHHHCCCC | 35.79 | 23927012 | |
| 654 | Phosphorylation | TASRFQNTIPCLGRE CHHHHHCCCCCCCCC | 18.60 | 28555341 | |
| 673 | Phosphorylation | GSTMFEGYCQKCFIE CCHHCHHHHHHHHHH | 5.63 | 20090780 | |
| 676 | Ubiquitination | MFEGYCQKCFIEAQN HCHHHHHHHHHHHHH | 27.79 | - | |
| 692 | Phosphorylation | RFHEAKRTEEQLRSS HHHHHHHHHHHHHHH | 43.07 | 29449344 | |
| 698 | Phosphorylation | RTEEQLRSSQRRDVP HHHHHHHHHHHCCCC | 39.14 | 29449344 | |
| 699 | Phosphorylation | TEEQLRSSQRRDVPR HHHHHHHHHHCCCCC | 22.67 | 29449344 | |
| 715 | Ubiquitination | TQSTSRPKCARASCK CCCCCCHHHHHHHHH | 39.14 | 22817900 | |
| 722 | Acetylation | KCARASCKNILACRS HHHHHHHHHHEECCC | 44.52 | 25953088 | |
| 722 | Ubiquitination | KCARASCKNILACRS HHHHHHHHHHEECCC | 44.52 | 23000965 | |
| 729 | Phosphorylation | KNILACRSEELCMEC HHHEECCCHHHHHHC | 34.99 | 30108239 | |
| 778 | Phosphorylation | GNAKCNGYCNECFQF CCCCCCCCHHHHHHH | 4.33 | 20090780 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TNAP3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TNAP3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-459, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-575, AND MASSSPECTROMETRY. | |